Italia markets closed

BMY Jun 2025 65.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,5000-0,0400 (-7,41%)
Alla chiusura: 01:58PM EDT
Schermo intero
Chiusura precedente0,5400
Aperto0,5000
Denaro0,4800
Lettera0,7300
Prezzo d'esercizio65,00
Scadenza2025-06-20
Min-Max giorno0,5000 - 0,5000
Contratto - Min-MaxN/D
Volume1
Open Interest112
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri